Construction of the core symptom cluster management program for patients with lung cancer undergoing chemotherapy: a Delphi study

Author:

Zhang Le1,Luo Yuanyuan1,Mao Dongmei1,Zhu Benxiang1,Yang Zhihui1,Cui Cui2,Miao Jingxia3,Zhang Lili1

Affiliation:

1. Southern Medical University

2. Zhujiang Hospital

3. Nanfang Hospital

Abstract

Abstract

Background: In recent years, the incidence of cancer has been on the rise worldwide due to environmental pollution, poor lifestyle habits, and increasing medical diagnoses. In China, the incidence and mortality of lung cancer both rank first among malignant tumors. In the process of cancer diagnosis and treatment, patients with lung cancer experience a serious symptom burden. Inadequate symptom management will aggravate the physical and mental pain of patients, and even delay or interrupt the treatment of the disease. Therefore, it is urgent to provide scientific symptom management programs for medical staff and patients with lung cancer. Objective: To construct the core symptom cluster management program for patients with lung cancer undergoing chemotherapy. Methods: Under the guidance of Symptom Management Theory, the draft program was formed through the literature supplement and clinical expert meeting based on the best evidence summary, and the final program was formed after two rounds of Delphi with 17 experts. Results: The draft program contains 35 entries in 3 time dimensions and 16 intervention dimensions. The final program, formed after two rounds of Delphi, consists of 12 entries in 7 different dimensions. In both rounds, Delphi issued and recovered 17 questionnaires, and the recovery rate was 100%. The expert authority coefficient was 0.888. The submission rate of expert opinions was 82.35% and 58.82%. The mean values of importance were 3.765-4.647 and 4.410-4.820. The full score frequency was 23.5-76.5 and 58.8-88.2. The coefficient of variation was 0.130-0.280 and 0.110-0.197. The Kendall’s W was 0.467 and 0.523, P < 0.05. The expert approval rate for the clinical usability of each item was 94.1%-100%. Conclusion: Under the guidance of Symptom Management Theory, the core symptom cluster management program for patients with lung cancer undergoing chemotherapy established in this study is scientific and credible, with clinical operability, and can guide medical staff and patients with lung cancer to carry out symptom management in complex clinical environments.

Publisher

Research Square Platform LLC

Reference65 articles.

1. Cancer statistics for the year 2020: an overview;Ferlay J;Int J Cancer,2021

2. 2020 global cancer statistics report interpretation;Liu Z;Electron J Integr Cancer Therapy,2021

3. Exploring symptom clusters and their measurements in patients with lung cancer: a scoping review for practice and research;Karlsson K;Oncol Nurs Forum,2023

4. Management of locally advanced non-small cell lung cancer: state of the art and future directions;Miao D;Cancer Commun (Lond),2024

5. Clinical status and perspective on the application of immunotherapy combined with chemotherapy in advanced non-small cell lung cancer: a review;Wang T;Chin Clin Oncol,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3